Pinnacle Bancorp, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pinnacle Bancorp, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$31,538
-1.5%
2,0390.0%0.01%0.0%
Q2 2023$32,028
-4.7%
2,0390.0%0.01%
-8.3%
Q1 2023$33,598
+104893.8%
2,0390.0%0.01%0.0%
Q4 2022$32
-99.8%
2,039
+28.9%
0.01%
+33.3%
Q3 2022$21,000
-4.5%
1,5820.0%0.01%0.0%
Q2 2022$22,000
-18.5%
1,582
-15.9%
0.01%0.0%
Q1 2022$27,000
+3.8%
1,8820.0%0.01%0.0%
Q4 2021$26,000
-40.9%
1,882
-29.4%
0.01%
-50.0%
Q3 2021$44,000
-4.3%
2,667
-2.5%
0.02%
-14.3%
Q2 2021$46,0000.0%2,736
+8.3%
0.02%
-4.5%
Q1 2021$46,000
+170.6%
2,527
+172.9%
0.02%
+120.0%
Q4 2020$17,0000.0%9260.0%0.01%
-16.7%
Q3 2020$17,0000.0%9260.0%0.01%
-7.7%
Q2 2020$17,000
+21.4%
9260.0%0.01%
+8.3%
Q1 2020$14,000
-39.1%
926
-19.2%
0.01%
-25.0%
Q4 2019$23,000
+15.0%
1,1460.0%0.02%
+45.5%
Q3 2019$20,0000.0%1,1460.0%0.01%0.0%
Q2 2019$20,000
-13.0%
1,1460.0%0.01%
-15.4%
Q1 2019$23,0001,1460.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders